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Editors: Anton N. Sidawy and Bruce A. PerlerA single nucleotide polymorphism in the p27Kip1 gene is
associated with primary patency of lower extremity vein
bypass grafts
Michael S. Conte, Christopher D. Owens, Michael Belkin,
Mark A. Creager, Karen L. Edwards, Warren J. Gasper,
Richard D. Kenagy, Renee C. LeBoeuf, Michael Sobel,
Alexander Clowes
Objective: Factors responsible for the variability in
outcomes after lower extremity vein bypass grafting
(LEVBG) are poorly understood. Recent evidence has sug-
gested that a single nucleotide polymorphism (SNP) in the
promoter region of the p27Kip1 gene, a cell-cycle regulator,
is associated with coronary in-stent restenosis. We
hypothesized an association with vein graft patency.
Methods: This was a retrospective genetic association study
nested within a prospective cohort of 204 patients from
three referral centers undergoing LEVBG for claudication or
critical ischemia. The main outcome measure was primary
vein graft patency.
Results: All patients were followed up for a minimum of 1
year with duplex graft surveillance (median follow-up,
893 days; interquartile range, 539-1315). Genomic DNA was
isolated and SNP analysis for the p27Kip1-838C>A variants
was performed. Allele frequencies were correlated with
graft outcome using survival analysis and Cox proportional
hazards modeling. The p27Kip1-838C>A allele frequencies
observed were CA, 53%; CC, 30%; and AA, 17%, satisfying
Hardy-Weinberg equilibrium. Race (P ¼ .025) and history of
coronary artery disease (P ¼ .027) were different across the
genotypes; all other baseline variables were similar. Primary
graft patency was greater among patients with the -838AA
genotype (75% AA vs 55% CA/CC at 3 years; P ¼ .029). In
a Cox proportional hazards model including age, sex, race,
diabetes, critical limb ischemia, redo (vs primary) bypass,
vein type, and baseline C-reactive protein level, the p27Kip1-
838AA genotype was signiﬁcantly associated with higher
graft patency (hazard ratio for failure, 0.4; 95% conﬁdence
interval, 0.17-0.93). Genotype was also associated with
early (0-1 month) changes in graft lumen diameter by
ultrasound imaging.
Conclusions: These data suggest that the p27Kip1-838C>A
SNP is associated with LEVBG patency and, together with
previous reports, underscore a central role for p27Kip1 in the
generic response to vascular injury.*Full articles available online at www.jvascsurg.org
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http://dx.doi.org/10.1016/S1078-5884(13)00218-9Changing presentation of knee dislocation and vascular
injury from high-energy trauma to low-energy falls in the
morbidly obese
Andrew G. Georgiadis, Farah H. Mohammad, Kristin C.
Mizerik, Timothy J. Nypaver, Alexander D. Shepard
Objective: Reports in the literature of low-energy (LE) knee
dislocation (KD) in obese patients have been increasing. This
study was undertaken to deﬁne the risk factors for KD by LE
mechanisms and the outcomes of these patients compared
with those with high-energy (HE) trauma.
Methods: All patients with a complete KD presenting to the
emergency department of a large urban level I trauma
center were reviewed. Patient information collected
included age, sex, weight, height, body mass index (BMI),
injury mechanism, neurovascular and orthopedic injuries,
and operations performed to treat vascular injuries. Risk
factors for KD and concomitant injuries were compared
between HE traumatic dislocations and LE dislocations in
obese patients (BMI >30 kg/m2), including stratiﬁcation for
increasing levels of obesity.
Results: Between January 1995 and April 2012, 53 patients
with KD were identiﬁed. The mechanism of injury was HE in
28 (53%) and LE in 25 (47%). Of the LE KDs, 18 (72%) were
related to obesity (BMI >30 kg/m2). Obese patients with LE
trauma were more likely to have associated nerve injuries
(50% vs 6%; P < .001), vascular injuries requiring inter-
vention (33% vs 9%; P ¼ .048), and vascular surgical repairs
(28% vs 6%; P ¼ .038) than patients with HE traumatic
dislocations. These rates were highest in the patients with
a BMI >40 kg/m2. Although all LE KDs in the obese involved
an isolated extremity, the hospital lengths of stay were
comparable to those with HE KDs who frequently had
multisystem trauma (8.7 vs 11.4 days). During a 17-year
period, LE KDs in the obese represented an increasing
proportion, from 17% in 1995 to 2000 up to 53% in 2007 to
2012, and the eventual majority of all KDs at our institution
(P ¼ .024).
Conclusions: LE KDs in obese patients are becoming
increasingly prevalent. These patients are more likely to
have nerve and vascular injuries and are more likely to
undergo vascular repair than patients with HE trauma. The
epidemic of obesity in the United States presents unique
challenges in the identiﬁcation and treatment of patients
with LE KD and their associated injuries.
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endovascular repair of juxtarenal and pararenal aortic
aneurysms
Andrew Holden, Renato Mertens, Andrew Hill, Leopoldo
Mariné, Daniel G. Clair
Objective: Customized fenestrated endovascular stent grafts
have been investigated as an alternative to open surgery for
repair of more complex juxtarenal aortic aneurysms (JAAs).
The substantial time required to design and manufacture
these devices has led to the desire for a standardized fenes-
trated endovascular system. We report the initial pilot study
results of a potential “off-the-shelf” fenestrated device
system to assess its initial safety and feasibility for endovas-
cular repair of JAAs and pararenal aortic aneurysms (PAAs).
Methods: Following ethics committee approvals, consenting
patients were evaluated for eligibility. Patients with aneu-
rysms abutting or including the renal artery oriﬁces who were
not candidates for standard infrarenal endograft placement
because of proximal aortic neck morphology were further
assessed for anatomic suitability for this “off-the-shelf”
device. There were a number of anatomic requirements, the
most important being a stable infra-superior mesenteric
artery aortic neck length 15 mm. Patients are assessed in-
hospital and in follow-up at 1, 6, and 12 months, and annually
thereafter to 5 years for adverse events and using contrast-
enhanced computed tomography angiography with Core
Laboratory interpretation of renal perfusion, device integrity,
migration, endoleak, and aneurysm morphology.
Results: Fifteen patients (87% male) with JAAs (93%) or PAAs
(6.7%) presented atmean age of 77 years (range, 66-85 years)
and with mean sac diameter of 5.9 cm (range, 5.1-7.9 cm).
Four Ventana fenestrated stent graft models having aligned
fenestrations (three models) or offset fenestrations (one
model) and renal stent grafts were successfully implanted
among the patients, and all renal and visceral arteries were
preserved. Mean endovascular procedure time was 108
minutes (range, 71-212 minutes) with mean contrast usage
and ﬂuoroscopy time of 254 mL (range, 67-420 mL) and 55
minutes (range, 27-104 minutes), respectively. Five patients
received blood products. Mean time to hospital discharge
was 3.3 days (range, 2-9 days). In follow-up to 6 months and 1
year, no rupture, conversion to open repair, migration, type I/
III endoleak, or renal loss/infarcts were observed. Two late
nonaneurysm-related deaths have occurred. One secondary
procedure for iliac limb kinking/occlusion and one secondary
procedure for renal artery stenosis have been performed.
Conclusions: Early experience supports procedural and initial
postprocedural safety and demonstrates proof of concept for
the off-the-shelf Ventana fenestrated system for the endo-
vascular repair of JAAs and PAAs in selected patients.
Continued follow-up and expanded multicenter clinical
experience is warranted.
Incidence and treatment results of Endurant endograft
occlusion
Laura van Zeggeren, Frederico Bastos Gonçalves, Joost A.
van Herwaarden, Herman J.A. Zandvoort, Debora A.B.Werson, Jan-Albert Vos, Frans L. Moll, Hence J. Verhagen,
Jean-Paul P.M. de Vries
Objective: The Endurant endograft (Medtronic Inc, Minne-
apolis, Minn) is a new-generation device speciﬁcally devel-
oped to perform well in complex abdominal aortic
aneurysm anatomy. Previous reports on the 1- and 2-year
results of endovascular aneurysm repair (EVAR) with the
Endurant endograft showed excellent outcome, including
prevention of migration and type I endoleaks, but occur-
rence and outcome of post-EVAR occlusion have not been
determined in a large multicenter patient cohort with
midterm follow-up, which is the objective of this study.
Methods: Data of consecutive patients treated with the
Endurant from December 2007 to April 2012 in three Dutch
tertiary vascular referral hospitals were prospectively
gathered and retrospectively analyzed. Follow-up consisted
of regular ofﬁce visits, computed tomography angiography
at 1 and 12 months after EVAR, and subsequently, duplex
ultrasound imaging or computed tomography angiography
at regular intervals. Patients with ruptured aneurysms or
with earlier abdominal aortic surgery were excluded. The
incidence and clinical outcome of endograft occlusions were
analyzed. An expert review board assessed all cases in the
search for possible causes of occlusion.
Results: Included were 496 patients (87.7% male), who were
a median age of 74 years (range, 68-78 years). Median follow-
up was 1.7 years (range, 0-4.6 years). Twenty graft occlusions
(4.0%) occurred during follow-up. Median time between
primary EVARanddetection of the occlusionwas 1month,with
55% occurring 60 postoperative days and 90% 1 year. No
associationwas found between occlusion and sex (P¼.28), age
(P ¼ .96), or use of an aortouniiliac device (P ¼ .66). Technical
error was the considered cause of the occlusion in 12 patients
(60%). The estimated freedom from occlusion was 98.4% at 30
days, 95.7% at 1 year, and 95.3% at 3 years. Presenting symp-
toms of occlusion were acute limb ischemia in 50%. Treatment
was surgical (75%) or percutaneous (25%). Successful revas-
cularization was achieved in 17 of 20 patients, but reocclusions
occurred in ﬁve, resulting in a transfemoral amputation in one
patient. Occlusion-related mortality was 0.6% (3 of 496).
Conclusions: At a median follow-up of 1.7 years, Endurant
endograft occlusion occurred in 4.0% of 496 patients. Most
occlusions occurred 2 months after EVAR, and rarely after
1 year. A technical justiﬁcation for occlusion could be found
for 60% of patients. A more liberal intraoperative and early
postoperative (re)intervention strategy may reduce the
occlusion rates and improve outcome.Gender differences in abdominal aortic aneurysm
presentation, repair, and mortality in the Vascular Study
Group of New England
Ruby C. Lo, Rodney P. Bensley, Allen D. Hamdan, Mark
Wyers, Julie E. Adams, Marc L. Schermerhorn
Objective: Prior studies of gender differences in abdominal
aortic aneurysm (AAA) repair suggest there may be differ-
ences in presentation, suitability for endovascular aneurysm
repair (EVAR), and outcomes between men and women.
Abstracts 533Methods: We used the Vascular Study Group of New
England database to identify all patients undergoing EVAR
or open AAA repair. We analyzed demographics, comor-
bidities, and procedural, and perioperative data. Results
were compared using the Fisher exact test and the Student
t-test. Multivariable logistic regression and Cox proportional
hazards modeling were performed to identify predictors of
mortality.
Results: We identiﬁed 4026 patients (78% men) who
underwent AAA repair (54% EVAR). Women were less likely
than men to undergo EVAR for intact aneurysms (50% vs
60% of intact AAA repair; P < .001) but not for ruptured
aneurysms (26% vs 20%; P ¼ .23). Women were older
(median age, 75 vs 72 years for intact; P < .001; 78 vs 73
years for rupture; P< .001) with smaller aortic diameters (57
vs 59 mm for elective; P < .001; 71 vs 79 mm for rupture;
P < .001). Arterial injury was more common in women (5.4%
vs 2.7%; P ¼ .013) among patients undergoing EVAR for
intact aneurysms. Women stayed in the hospital longer (4.3
vs 2.7 days; P ¼ .018) and had lower odds of being dis-
charged home, even after adjusting for age. Among patients
undergoing open repair for intact aneurysms, women more
frequently experienced leg ischemia/emboli (4% vs 1%; P ¼
.001) and bowel ischemia (5% vs 3%; P ¼ .044). Women had
higher 30-day mortality after OAR for intact (4% vs 2%; P ¼
.03) and rupture (48% vs 34%; P ¼ .03) repairs. However, 30-
day mortality after EVAR was similar for intact (1% in men vs
1% in women; P ¼ .57) and rupture (29% in men vs 27% in
women; P > .99) repairs. Late survival was worse in women
than men only for patients undergoing open repair of
ruptured aneurysms (hazard ratio, 1.8; 95% conﬁdence
interval, 1.0-3.1; P ¼ .04). After controlling for age, type of
repair, urgency at presentation (ie, elective/intact vs
ruptured), comorbidities, and other relevant risk factors,
gender was not predictive of 30-day or 1-year mortality.
Conclusions: Women with AAAs are being treated at older
ages and smaller AAA diameters and are undergoing
rupture repair at smaller diameters than men. Women are
more likely to experience perioperative complications as
a result of less favorable vascular anatomy. Age >80 years,
comorbidity, presentation, and type of repair are more
important predictors of mortality than gender.Secondary interventions after elective thoracic
endovascular aortic repair for degenerative aneurysms
Cheong J. Lee, Heron E. Rodriguez, Melina R. Kibbe, S. Chris
Malaisrie, Mark K. Eskandari
Objective: We assessed the incidence and outcomes of
graft-related secondary interventions (ie, open conversion
or proximal or distal extensions) after elective thoracic
endovascular aortic repair (TEVAR) for aneurysmal disease.
Methods: An institutional review of TEVAR for descending
thoracic aortic aneurysms (DTAAs), between 2000 and
2011, was performed. Only elective TEVAR for DTAA using
commercially available endografts was selected. Emergent
cases, nonaneurysmal aortic pathology (ie, transection,pseudoaneurysm, dissection), and cases that used physi-
cian-modiﬁed devices were excluded. The incidence of
unplanned graft-related secondary interventions was
examined and outcomes were analyzed.
Results: During the study period, 83 patients underwent
elective TEVAR for DTAA that met the inclusion criteria.
Subsequent graft-related secondary interventions were
required in eight patients (10%). The mean interval to the
secondary intervention was 31.8 months. Endoleak was the
most common indication. Patients who required secondary
interventions were signiﬁcantly younger (mean age, 58 
12 vs 69  11 years; P < .05). Operative mortality (<30 day)
was zero, with one aneurysm-related late death occurring at
2 years after the secondary intervention. Factors that pre-
disposed the need for secondary interventions were fusi-
form morphology of the aneurysm (P ¼ .05) and extent of
graft coverage in the proximal landing zone <3 cm (P <
.05). Size of the aneurysm treated and the type of device
used were not signiﬁcant factors leading to secondary
intervention.
Conclusions: Intermediate and long-term results of elective
TEVAR for DTAA demonstrate good durability, with
acceptable rates of graft-related secondary interventions.
Age, fusiform aneurysm morphology, and extent of proximal
landing zones <3 cm were signiﬁcant factors that led to
subsequent secondary interventions.Results of elective and emergency endovascular repairs of
popliteal artery aneurysms
Magdiel Trinidad-Hernandez, Joseph J. Ricotta, Peter Glo-
viczki, Manju Kalra, Gustavo S. Oderich, Audra A. Duncan,
Thomas C. Bower
Objective: Endovascular repair has emerged as a treatment
option for popliteal artery aneurysms. Our goal was to
analyze outcomes of elective and emergency endovascular
popliteal artery aneurysm repair (EVPAR).
Methods: This was a retrospective review of clinical data of
patients treated with EVPAR at our institution between 2004
and 2010. Stent-related complications, patency, outcome
limb salvage, and survival were evaluated and analyzed.
Results: EVPAR was performed in 31 limbs of 25 patients
(mean age, 81 years; range, 65-89 years). Repair was elec-
tive in 19 limbs (61%) and emergent in 12 (39%). One
aneurysm ruptured and 11 presented with acute throm-
bosis. All 11 underwent thrombolysis before EVPAR.
Patients were implanted with a mean of 2.1 Viabahn stent
grafts (range, 1-4). Ten procedures (32%) were performed
percutaneously and 21 by femoral cutdown. Technical
success was 97%. Overall 30-day mortality was 6.4%, with
0% in the elective group, and 16.7% in the emergent group
(P ¼ .14). Early complications included graft thrombosis in
two limbs (6.4%) and hematoma in four (13%), all after
percutaneous repair. Myocardial infarction and thrombol-
ysis-associated intracranial hemorrhage occurred in one
patient each (3.2%). The 30-day primary and secondary
patencies were 93.6% and 96.7%, respectively, and were
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tively, for the emergent group. Mean follow-up was 21.3
months (range, 1-75 months). Primary patency at 1 year
was 86% (95% for elective, 69% for emergent; P ¼ .56),
secondary patency at the same time was 91% (elective,
100%; emergent, 91%). One-year limb salvage was 97%.
Two-year survival was 91% for the elective group and 73%
for the emergent group (P ¼ .15). Five stent occlusions were
encountered after 30 days, four in the elective group. Four
underwent successful reintervention, two had bypass, and
two had thrombolysis, followed by angioplasty. The ﬁfth
patient was asymptomatic and nonambulatory and remains
under observation. Stent graft infolding occurred in one
limb (3.2%), with no clinical sequelae. No stent migration or
separation was observed. One stent fracture was noted in an
asymptomatic patient. Three (10%) type II endoleaks were
detected but none had aneurysm expansion. One (3.2%)
type I endoleak was treated percutaneously with placement
of an additional stent graft. Overall, major adverse events,
including death, graft occlusion with or without reoperation,
or reoperation for endoleak or stent infolding occurred after
11 procedures (35.5%). On univariate analysis, no factors
predicted stent failure, including runoff, antiplatelet therapy,
emergency repair, number of stents implanted, heparin
bonding of the stent, or degree of stent oversizing.
Conclusions: These results support elective EVPAR in
anatomically suitable patients with increased risk for open
repair; however, major adverse events after EVPAR, mainly
after emergency repairs, are frequent. A prospective
randomized multicenter study to justify EVPAR in the
emergent setting is warranted.Race as a predictor of morbidity, mortality, and neurologic
events after carotid endarterectomy
Hilary A. Brown, Michael C. Sullivan, Richard G. Gusberg,
Alan Dardik, Julie Ann Sosa, Jeffrey E. IndesObjective: Racial disparities in the outcomes of patients
undergoing carotid endarterectomy (CEA) have been
reported. We sought to examine the contemporary rela-
tionship between race and outcomes and to report post-
discharge events after CEA.
Methods: The American College of Surgeons National
Surgical Quality Improvement Program Participant Use Data
Files were reviewed to identify all CEAs performed from
2005 to 2010 by vascular surgeons. The inﬂuence of race on
outcomes was examined. Multivariate analysis was per-
formed using variables found to be signiﬁcant on bivariate
analysis. The primary outcomes were stroke and mortality.
Secondary outcomes were other 30-day complications,
including postdischarge events.
Results: CEA was performed on 29,114 white patients
(95.7%) and on 1316 black patients (4.3%); the overall
stroke and mortality rates were 1.65% and 0.7%, respec-
tively. The stroke rate was 1.6% for whites and 2.5% blacks
(P ¼ .009). The 30-day mortality rate was 0.7% for whites
and 1.4% for blacks (P ¼ .002). There was a longer operating
time (P < .001) and total length of stay (P < .001), more
postoperative pneumonias (P ¼ .049), unplanned intuba-
tions (P < .001), ventilator dependence (P < .001), cardiac
arrests (P < .001), bleeding requiring transfusions (P ¼
.024), and reoperations within 30 days (P ¼ .021) among
black patients. Multivariate logistic regression modeling
identiﬁed black race as an independent risk factor for 30-
day mortality (odds ratio, 1.9; P ¼ .007). Black patients also
had a greater proportion of in-hospital deaths than white
patients (73.7% vs 43.1%; P ¼ .01). There was no between-
group difference in the rate of postdischarge strokes. Thirty-
six percent of all strokes occurred after discharge at a mean
of 8.3 days, and 54.3% of deaths occurred after discharge at
a mean of 11 days.
Conclusions: Black race is an independent risk factor for 30-
day mortality after CEA. A signiﬁcant proportion of strokes
and deaths occur after discharge in both racial groups
evaluated.
